PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer [0.03%]
PARP-ish:靶向PARP的分子理解和临床试验中的空白加剧了前列腺癌的种族差异
Moriah Cunningham,Matthew J Schiewer
Moriah Cunningham
PARP is a nuclear enzyme with a major function in the DNA damage response. PARP inhibitors (PARPi) have been developed for treating tumors harboring homologous recombination repair (HRR) defects that lead to a dependency on PARP. There are ...
Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to Chemoradiotherapy [0.03%]
用氘代谢磁共振区分胶质母细胞瘤代谢亚型并检测同步放化疗早期疗效
Jacob C M Low,Jianbo Cao,Friederike Hesse et al.
Jacob C M Low et al.
Metabolic subtypes of glioblastoma (GBM) have different prognoses and responses to treatment. Deuterium metabolic imaging with 2H-labeled substrates is a potential approach to stratify patients into metabolic subtypes for targeted treatment...
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer [0.03%]
CRISPR-Cas9筛选鉴定出KRAS诱导的COX2是肺癌免疫疗法耐药性的驱动因素
Jesse Boumelha,Andrea de Castro,Nourdine Bah et al.
Jesse Boumelha et al.
Oncogenic KRAS impairs antitumor immune responses. As effective strategies to combine KRAS inhibitors and immunotherapies have so far proven elusive, a better understanding of the mechanisms by which oncogenic KRAS drives immune evasion is ...
Correction: Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors [0.03%]
订正:全面代谢追踪揭示了半胱氨酸在哺乳动物组织和肿瘤中的起源和分解代谢路径
Sang Jun Yoon,Joseph A Combs,Aimee Falzone et al.
Sang Jun Yoon et al.
Published Erratum
Cancer research. 2024 Apr 15;84(8):1372. DOI:10.1158/0008-5472.CAN-24-0459 2024
Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ [0.03%]
关于纠正MNK1/NODAL信号促进乳腺导管原位癌侵袭进展的通知
Qianyu Guo,Vivian Z Li,Jessica N Nichol et al.
Qianyu Guo et al.
Published Erratum
Cancer research. 2024 Apr 15;84(8):1373. DOI:10.1158/0008-5472.CAN-24-0461 2024
Purva H Rumde,Timothy F Burns
Purva H Rumde
Residual cancer cells persist even after targeted therapies, serving as a reservoir for the subsequent acquisition of genetic alterations that lead to acquired drug resistance and tumor relapse. These initial drug-tolerant persisters (DTP) ...
Unlocking the Role of Age-Related Changes to Fibroblasts in Pancreatic Cancer [0.03%]
年龄相关成纤维细胞改变在胰腺癌中的作用机制探究
Achinoam Isaacson,Debra Barki,Ruth Scherz-Shouval
Achinoam Isaacson
Pancreatic cancer prevalence increases with age, and disease prognosis is poorer in older individuals. The increased prevalence is driven, undoubtedly, by the multistep accumulation of oncogenic mutations in cancer cells with age. However, ...
Pushing the Frontiers of Cancer Research: Highlights from the Frontiers in Cancer Science Conference 2023 [0.03%]
推动癌症研究的前沿:来自2023年癌症科学前沿大会的亮点报告
Yi Fei Lee,Leilei Chen,Valerie Chew et al.
Yi Fei Lee et al.
The 15th annual Frontiers in Cancer Science (FCS) conference gathered scientific experts who shared the latest research converging upon several themes of cancer biology. These themes included the dysregulation of metabolism, cell death, and...
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations [0.03%]
蛋白基因组分析发现雌激素信号通路可作为表皮生长因子受体和间变性淋巴瘤激酶野生型从不吸烟肺腺癌患者的治疗靶点
Seung-Jin Park,Shinyeong Ju,Sung-Ho Goh et al.
Seung-Jin Park et al.
Never-smoker lung adenocarcinoma (NSLA) is prevalent in Asian populations, particularly in women. EGFR mutations and anaplastic lymphoma kinase (ALK) fusions are major genetic alterations observed in NSLA, and NSLA with these alterations ha...
MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer [0.03%]
MILIP与tRNA结合促进蛋白质合成驱动三阴性乳腺癌发展
Si Min Zheng,Yu Chen Feng,Qin Zhu et al.
Si Min Zheng et al.
Patients with triple-negative breast cancer (TNBC) have a poor prognosis due to the lack of effective molecular targets for therapeutic intervention. Here we found that the long noncoding RNA (lncRNA) MILIP supports TNBC cell survival, prol...